Have a
regulatory affairs
challenge?
Pharma and Biotech Latest Insights
Curated Regulatory Intelligence Augmented by AI
Pharma and Biotech
Thailand: Updated Dosage Limits for Drugs Containing Fat-Soluble Vitamins
The Ministry of Public Health in Thailand has unveiled a draft notification outlining updated dosage...
Read more
Pharma and Biotech
EU Committees Adopt Position on Green Claims Directive: Penalties, Verifica…
The Internal Market and Environment committees of the EU Parliament have adopted their position on...
Read more
Pharma and Biotech
Proposed changes to the Pharmaceutical Advertising Advisory Board (PAAB) Co…
Health Canada is currently scrutinizing a significant revamp of pharmaceutical advertising standards proposed by the...
Read more
Pharma and Biotech
TGA Seeks Input: Adoption of International Scientific Guidelines
The Therapeutic Goods Administration (TGA) Australia is actively seeking public input on the adoption of...
Read more
Pharma and Biotech
Thai FDA’s Proposed Draft Notification: Annual Safety Reports for Con…
Thai FDA proposes a draft Notification mandating annual safety reports for terminated or completed clinical...
Read more
Pharma and Biotech
US FDA Eases Informed Consent for Minimal Risk Clinical Trials
FDA Implements 21st Century Cures Act: Effective 30 days post-publication, ensuring rights and safety of...
Read more
Pharma and Biotech
FDA Proposes Human Abuse Potential Study for Kratom
FDA allocates $2 million for institutions conducting a Human Abuse Potential (HAP) study on botanical...
Read more
Pharma and Biotech
Australia: TGA Repeals Advertising Permission for Nicotine Products
The Therapeutic Goods Administration (TGA) has repealed the Advertising Permission for Nicotine, effective from 1...
Read more
Pharma and Biotech
Increased Risk of Neurodevelopmental Disorders in Children Linked to Valpro…
New research indicates a higher risk of neurodevelopmental disorders in children when fathers took valproate...
Read more
Pharma and Biotech
ANVISA adopts new flows to request for consent to import experimental medic…
ANVISA (Brazil) Introduces Streamlined Processes for Importing Experimental Medicines: New procedures exclude pre-boarding inspections for...
Read more